GBIO
Price
$6.18
Change
-$0.46 (-6.93%)
Updated
Oct 17 closing price
Capitalization
41.63M
18 days until earnings call
Intraday Buy/Sell Signals
RGNX
Price
$11.73
Change
-$0.61 (-4.94%)
Updated
Oct 17 closing price
Capitalization
592.53M
18 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

GBIO vs RGNX

Header iconGBIO vs RGNX Comparison
Open Charts GBIO vs RGNXBanner chart's image
Generation Bio
Price$6.18
Change-$0.46 (-6.93%)
Volume$31.15K
Capitalization41.63M
REGENXBIO
Price$11.73
Change-$0.61 (-4.94%)
Volume$392.97K
Capitalization592.53M
GBIO vs RGNX Comparison Chart in %
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. RGNX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a Hold and RGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (GBIO: $6.18 vs. RGNX: $11.73)
Brand notoriety: GBIO and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 11% vs. RGNX: 66%
Market capitalization -- GBIO: $41.63M vs. RGNX: $592.53M
GBIO [@Biotechnology] is valued at $41.63M. RGNX’s [@Biotechnology] market capitalization is $592.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 4 TA indicator(s) are bullish while RGNX’s TA Score has 4 bullish TA indicator(s).

  • GBIO’s TA Score: 4 bullish, 4 bearish.
  • RGNX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both GBIO and RGNX are a good buy in the short-term.

Price Growth

GBIO (@Biotechnology) experienced а +1.15% price change this week, while RGNX (@Biotechnology) price change was +7.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

GBIO is expected to report earnings on Nov 05, 2025.

RGNX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($593M) has a higher market cap than GBIO($41.6M). RGNX YTD gains are higher at: 51.746 vs. GBIO (-41.698). GBIO has higher annual earnings (EBITDA): -69.92M vs. RGNX (-129.93M). RGNX has more cash in the bank: 323M vs. GBIO (141M). RGNX has less debt than GBIO: RGNX (77.7M) vs GBIO (85.3M). RGNX has higher revenues than GBIO: RGNX (156M) vs GBIO (21.2M).
GBIORGNXGBIO / RGNX
Capitalization41.6M593M7%
EBITDA-69.92M-129.93M54%
Gain YTD-41.69851.746-81%
P/E RatioN/AN/A-
Revenue21.2M156M14%
Total Cash141M323M44%
Total Debt85.3M77.7M110%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
20
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GBIORGNX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHE440.569.64
+2.24%
Chemed Corp
SILA23.890.13
+0.55%
Sila Realty Trust Inc.
PKOH20.21-0.11
-0.54%
Park-Ohio Holdings Corp
BLK1161.16-10.20
-0.87%
Blackrock
RNXT1.12-0.05
-4.27%
RenovoRx

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CABA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CABA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-6.93%
CABA - GBIO
45%
Loosely correlated
-1.04%
MGNX - GBIO
44%
Loosely correlated
-2.37%
IDYA - GBIO
42%
Loosely correlated
+5.67%
SYRE - GBIO
42%
Loosely correlated
+1.03%
RGNX - GBIO
40%
Loosely correlated
-4.94%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with SYRE. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-4.94%
SYRE - RGNX
55%
Loosely correlated
+1.03%
DNLI - RGNX
54%
Loosely correlated
-0.36%
KYMR - RGNX
53%
Loosely correlated
-1.04%
BEAM - RGNX
53%
Loosely correlated
+0.74%
VYGR - RGNX
53%
Loosely correlated
-7.13%
More